# Cognex Corporation (CGNX) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Technology / Electronic Equipment, Instruments & Components. Price $62.25, market value $10.5 billion.

## Valuation
- **P/E (trailing): 59.9×** (5-yr avg 51.7×, 3-yr avg 57.6×). Cognex Corporation trades at 59.9× trailing earnings, close to its own five-year average of 51.7×. The Technology median in the September 2026 study was 32.1×. Forward P/E is 30.8×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 3.18**. A PEG of 3.18 means the P/E is high relative to expected earnings growth; the price already assumes a lot.
- **Price / sales: 9.6×**. Each dollar of revenue is priced at 9.6×.
- **Price / book: 6.4×**. The shares trade at 6.4× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: 2.6%** (5-yr avg 2.5%). Free cash flow equals 2.6% of the market value, in line with its five-year average of 2.5%.
- **Earnings yield: 1.7%**. The inverse of the P/E: 1.7% of the price is earned each year.

## Profitability
- **Gross margin: 68.9%**. Cognex Corporation keeps 68.9% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: 21.9%**. 21.9% of revenue is left after running the business, a healthy level in most sectors.
- **Net margin: 11.5%**. 11.5% of each dollar of sales reaches the bottom line.
- **Return on equity: 7.7%**. 7.7% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on assets: 8.7%**. Each dollar of assets produces 8.7% of profit.

## Growth
- **Revenue growth (1 yr): 8.7%** (3-yr -0.4%/yr, 5-yr 4.2%/yr). Revenue grew 8.7% over the last year, against 4.2% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 9.7%** (3-yr -17.9%/yr, 5-yr -7.4%/yr). Earnings per share rose 9.7%, roughly in step with revenue.
- **Free-cash-flow growth (3 yr): 1.9%/yr**. Free cash flow has compounded at 1.9% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Current ratio: 3.80** (quick 3.80). Current assets cover the next year's liabilities 3.80 times.
- **Altman Z-score: 14.08**. A Z-score of 14.08 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 7/9**. 7 of 9 fundamental checks pass: strong and improving financials.

## Dividends
- **Dividend yield: 0.55%** ($0.34 per share, trailing). Cognex Corporation yields 0.55%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 48%** (21% of free cash flow). 48% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 4**. 4 straight years of increases.
- **Dividend growth (5 yr): -31.9%/yr** (1-yr 6.6%). The dividend has not grown over five years.

## Analyst view
- **Analyst consensus: buy** (19 analysts). 19 analysts cover Cognex Corporation; the consensus is buy, with an average price target of $80.05 (+29% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 41.3%** (YTD 73.5%, 3-mo 2.4%). The shares are up 41.3% over twelve months including dividends.
- **From 52-week high: -14.6%** (79.9% above the low). Trading 15% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 50**. An RSI of 50 is neutral.
- **Beta (1 yr): 1.90** (volatility 58%). Beta of 1.90 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=CGNX · Page: https://foliofundamentals.com/stocks/cgnx

Not investment advice.